Hepcidin: a new approach to iron overload

A world-first international trial of hepcidin to regulate iron absorption in haemochromatosis patients is underway, including sites in Brisbane, Sydney and Melbourne. The Phase 2 trial aims to compare weekly dosing of a synthetic human hepcidin versus placebo on markers of iron metabolism. If effective at preventing iron overload, the treatment may be a useful alternative ...

Already a member?

Login to keep reading.

© 2021 the limbic